EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of remimazolam sedation during neuraxial anesthesia on perioperative cognitive function in elderly patients: a multicenter randomized controlled study

Dan Qiao, Jia-Min Kang, Rui Zhang, Lin-Yue Zong, Ying Xu, Wei-Wei Zhang, Qi Zhou, Yan Li, Tao Han, Yue-Ming Zhang, Li-Jun Yin, Jin Xu und 8 weitere

Frontiers in Pharmacology · 28.04.2025 · 16

DOI: 10.3389/fphar.2025.1504813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 28.04.2025. Verfasst von Dan Qiao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin Research Institute of Anesthesiology, Tianjin, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin Municipality, Tianjin Municipal Bureau of Public Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Remimazolam, a novel ultra-short-acting benzodiazepine, is a potential sedative for non-general anesthesia surgery in the elderly. This study aimed to investigate the appropriate sedative dosage of remimazolam and its effects on perioperative cognitive function in elderly patients undergoing non-general anesthesia surgery.

Methods

This multicenter, placebo-controlled trial enrolled 330 elderly patients undergoing non-general anesthesia procedures at eight centers in China from July 2021 to February 2022, with 238 ultimately completing the study. The primary endpoints were the dose of successful sedation with remimazolam and the changes in perioperative cognitive function. Adverse events were recorded to assess drug safety.

Results

The induction dose of remimazolam for sedation in spinal anesthesia in elderly patients was 5.38 mg (95% confidence interval [CI], 5.20–5.56), maintained at a rate of 0.223 mg·kg −1 ·h −1 (95% CI, 0.201–0.237) with no serious adverse effects. Compared with the standard saline group, there was no statistical difference in the MMSE scores on Day 2 morning (P = 0.886), Day 2 afternoon (P = 0.864), and Day 7 (P = 0.613), and no statistical difference in the MoCA scores on Day 2 morning (P = 0.687), Day 2 afternoon (P = 0.827), and Day 7 (P = 0.483) in remimazolam group.

Conclusion

Remimazolam besylate is an effective sedative for elderly patients undergoing neuraxial anesthesia. It was successfully induced at a dose of 5.38 mg and maintained at 0.223 mg·kg −1 ·h −1 , demonstrating a good safety profile without affecting short-term postoperative cognitive function. Clinical Trial Registration http://www.chictr.org.cn (ChiCTR2100048744).

Schlagwörter

Stichwörter der Autor:innen

cognitive functionelderlyneuraxial anesthesiapostoperative cognitive complicationsremimazolamsedation

Autor:innen und Institutionen

  • Department of Anesthesiology, Tianjin Medical University General Hospital, Tianjin Research Institute of Anesthesiology, Tianjin, China.
  • Department of Anesthesiology, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.
  • Department of Anesthesiology, Chifeng Municipal Hospital, Chifeng, China.
  • Department of Anesthesiology, Tianjin Jizhou People's Hospital, Tianjin, China.
  • Department of Anesthesiology, Weifang People's Hospital, Weifang, Shandong, China.
  • Department of Anesthesiology, Tianjin Baodi Hospital, Tianjin, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Tianjin Municipality
  • Tianjin Municipal Bureau of Public Health

Zitieren

APA

Qiao, D., Kang, J. M., Zhang, R., Zong, L. Y., Xu, Y., Zhang, W. W., Zhou, Q., Li, Y., Han, T., Zhang, Y. M., Yin, L. J., Xu, J., Wang, S. S., Yuan, Y., Li, Q., Niu, K. J., Zheng, Y. X., Zhang, L. L., Li, Y. Z., & Yu, Y. H. (2025). The impact of remimazolam sedation during neuraxial anesthesia on perioperative cognitive function in elderly patients: a multicenter randomized controlled study. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1504813

Vancouver

Qiao D, Kang JM, Zhang R, Zong LY, Xu Y, Zhang WW, et al. The impact of remimazolam sedation during neuraxial anesthesia on perioperative cognitive function in elderly patients: a multicenter randomized controlled study. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1504813

BibTeX
@article{Qiao2025,
  author = {Qiao, Dan and Kang, Jia-Min and Zhang, Rui and Zong, Lin-Yue and Xu, Ying and Zhang, Wei-Wei and Zhou, Qi and Li, Yan and Han, Tao and Zhang, Yue-Ming and Yin, Li-Jun and Xu, Jin and Wang, Shou-Shi and Yuan, Yuan and Li, Qing and Niu, Kai-Jun and Zheng, Yu-Xin and Zhang, Lin-Lin and Li, Yi-Ze and Yu, Yong-Hao},
  title = {The impact of remimazolam sedation during neuraxial anesthesia on perioperative cognitive function in elderly patients: a multicenter randomized controlled study},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1504813}
}
Kostenlos starten →